nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—CYP2D6—Carteolol—glaucoma	0.122	0.198	CbGbCtD
Abiraterone—CYP2D6—Betaxolol—glaucoma	0.0822	0.134	CbGbCtD
Abiraterone—CYP2D6—Methazolamide—glaucoma	0.0623	0.102	CbGbCtD
Abiraterone—CYP3A4—Pilocarpine—glaucoma	0.0587	0.0956	CbGbCtD
Abiraterone—CYP2D6—Timolol—glaucoma	0.053	0.0864	CbGbCtD
Abiraterone—CYP3A4—Brinzolamide—glaucoma	0.046	0.075	CbGbCtD
Abiraterone—CYP2D6—Clonidine—glaucoma	0.045	0.0734	CbGbCtD
Abiraterone—CYP3A4—Dorzolamide—glaucoma	0.0444	0.0725	CbGbCtD
Abiraterone—CYP3A4—Methazolamide—glaucoma	0.0396	0.0646	CbGbCtD
Abiraterone—CYP3A4—Acetazolamide—glaucoma	0.0317	0.0516	CbGbCtD
Abiraterone—CYP3A4—Clonidine—glaucoma	0.0286	0.0467	CbGbCtD
Abiraterone—Testosterone—CYP1B1—glaucoma	0.00133	1	CrCbGaD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00105	0.00313	CcSEcCtD
Abiraterone—Mediastinal disorder—Travoprost—glaucoma	0.00105	0.00313	CcSEcCtD
Abiraterone—Arrhythmia—Dorzolamide—glaucoma	0.00105	0.00311	CcSEcCtD
Abiraterone—Discomfort—Apraclonidine—glaucoma	0.00105	0.00311	CcSEcCtD
Abiraterone—Angiopathy—Brinzolamide—glaucoma	0.00105	0.00311	CcSEcCtD
Abiraterone—Hypertension—Bimatoprost—glaucoma	0.00104	0.0031	CcSEcCtD
Abiraterone—Asthenia—Carteolol—glaucoma	0.00104	0.00309	CcSEcCtD
Abiraterone—Mediastinal disorder—Brinzolamide—glaucoma	0.00104	0.00309	CcSEcCtD
Abiraterone—Body temperature increased—Methazolamide—glaucoma	0.00104	0.00308	CcSEcCtD
Abiraterone—Arrhythmia—Brinzolamide—glaucoma	0.00103	0.00306	CcSEcCtD
Abiraterone—Chest pain—Bimatoprost—glaucoma	0.00103	0.00305	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Clonidine—glaucoma	0.00103	0.00305	CcSEcCtD
Abiraterone—Asthenia—Diclofenamide—glaucoma	0.00102	0.00304	CcSEcCtD
Abiraterone—Mental disorder—Travoprost—glaucoma	0.00102	0.00304	CcSEcCtD
Abiraterone—Pollakiuria—Clonidine—glaucoma	0.00102	0.00303	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00102	0.00303	CcSEcCtD
Abiraterone—Oedema—Apraclonidine—glaucoma	0.00102	0.00302	CcSEcCtD
Abiraterone—Hypokalaemia—Betaxolol—glaucoma	0.00101	0.00301	CcSEcCtD
Abiraterone—Mental disorder—Brinzolamide—glaucoma	0.00101	0.003	CcSEcCtD
Abiraterone—Infection—Apraclonidine—glaucoma	0.00101	0.003	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.001	0.00298	CcSEcCtD
Abiraterone—Nasopharyngitis—Betaxolol—glaucoma	0.000995	0.00296	CcSEcCtD
Abiraterone—Arrhythmia—Pilocarpine—glaucoma	0.000989	0.00294	CcSEcCtD
Abiraterone—Rash—Metipranolol—glaucoma	0.000987	0.00293	CcSEcCtD
Abiraterone—Skin disorder—Apraclonidine—glaucoma	0.000986	0.00293	CcSEcCtD
Abiraterone—Dermatitis—Metipranolol—glaucoma	0.000986	0.00293	CcSEcCtD
Abiraterone—Asthenia—Levobunolol—glaucoma	0.000983	0.00292	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Betaxolol—glaucoma	0.000982	0.00292	CcSEcCtD
Abiraterone—Infection—Bimatoprost—glaucoma	0.000978	0.00291	CcSEcCtD
Abiraterone—Urinary tract infection—Clonidine—glaucoma	0.000958	0.00285	CcSEcCtD
Abiraterone—Skin disorder—Bimatoprost—glaucoma	0.000956	0.00284	CcSEcCtD
Abiraterone—Diarrhoea—Carbachol—glaucoma	0.000952	0.00283	CcSEcCtD
Abiraterone—Asthenia—Methazolamide—glaucoma	0.000942	0.0028	CcSEcCtD
Abiraterone—Diarrhoea—Levobunolol—glaucoma	0.000937	0.00279	CcSEcCtD
Abiraterone—Discomfort—Acetazolamide—glaucoma	0.000936	0.00278	CcSEcCtD
Abiraterone—Cough—Brimonidine—glaucoma	0.000932	0.00277	CcSEcCtD
Abiraterone—Cardiac failure—Timolol—glaucoma	0.000932	0.00277	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000925	0.00275	CcSEcCtD
Abiraterone—Hypertension—Brimonidine—glaucoma	0.000922	0.00274	CcSEcCtD
Abiraterone—Insomnia—Apraclonidine—glaucoma	0.000918	0.00273	CcSEcCtD
Abiraterone—Myalgia—Brimonidine—glaucoma	0.000909	0.0027	CcSEcCtD
Abiraterone—Chest pain—Brimonidine—glaucoma	0.000909	0.0027	CcSEcCtD
Abiraterone—Vomiting—Diclofenamide—glaucoma	0.000906	0.00269	CcSEcCtD
Abiraterone—Dyspnoea—Apraclonidine—glaucoma	0.000905	0.00269	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000903	0.00268	CcSEcCtD
Abiraterone—Rash—Diclofenamide—glaucoma	0.000899	0.00267	CcSEcCtD
Abiraterone—Discomfort—Brimonidine—glaucoma	0.000899	0.00267	CcSEcCtD
Abiraterone—Diarrhoea—Methazolamide—glaucoma	0.000898	0.00267	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Betaxolol—glaucoma	0.000894	0.00266	CcSEcCtD
Abiraterone—Insomnia—Bimatoprost—glaucoma	0.000891	0.00265	CcSEcCtD
Abiraterone—Cough—Dorzolamide—glaucoma	0.00089	0.00265	CcSEcCtD
Abiraterone—Cough—Travoprost—glaucoma	0.000886	0.00263	CcSEcCtD
Abiraterone—Vomiting—Carbachol—glaucoma	0.000884	0.00263	CcSEcCtD
Abiraterone—Hypertension—Dorzolamide—glaucoma	0.000881	0.00262	CcSEcCtD
Abiraterone—Dyspnoea—Bimatoprost—glaucoma	0.000878	0.00261	CcSEcCtD
Abiraterone—Rash—Carbachol—glaucoma	0.000877	0.00261	CcSEcCtD
Abiraterone—Hypertension—Travoprost—glaucoma	0.000877	0.00261	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000877	0.00261	CcSEcCtD
Abiraterone—Dermatitis—Carbachol—glaucoma	0.000876	0.0026	CcSEcCtD
Abiraterone—Fatigue—Apraclonidine—glaucoma	0.000876	0.0026	CcSEcCtD
Abiraterone—Cough—Brinzolamide—glaucoma	0.000875	0.0026	CcSEcCtD
Abiraterone—Oedema—Brimonidine—glaucoma	0.000872	0.00259	CcSEcCtD
Abiraterone—Chest pain—Dorzolamide—glaucoma	0.000869	0.00258	CcSEcCtD
Abiraterone—Constipation—Apraclonidine—glaucoma	0.000868	0.00258	CcSEcCtD
Abiraterone—Hyperglycaemia—Betaxolol—glaucoma	0.000868	0.00258	CcSEcCtD
Abiraterone—Dyspepsia—Bimatoprost—glaucoma	0.000867	0.00258	CcSEcCtD
Abiraterone—Infection—Brimonidine—glaucoma	0.000866	0.00257	CcSEcCtD
Abiraterone—Hypertension—Brinzolamide—glaucoma	0.000866	0.00257	CcSEcCtD
Abiraterone—Chest pain—Travoprost—glaucoma	0.000865	0.00257	CcSEcCtD
Abiraterone—Myalgia—Travoprost—glaucoma	0.000865	0.00257	CcSEcCtD
Abiraterone—Pneumonia—Betaxolol—glaucoma	0.000863	0.00256	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000859	0.00255	CcSEcCtD
Abiraterone—Discomfort—Dorzolamide—glaucoma	0.000858	0.00255	CcSEcCtD
Abiraterone—Infestation—Betaxolol—glaucoma	0.000858	0.00255	CcSEcCtD
Abiraterone—Infestation NOS—Betaxolol—glaucoma	0.000858	0.00255	CcSEcCtD
Abiraterone—Discomfort—Travoprost—glaucoma	0.000854	0.00254	CcSEcCtD
Abiraterone—Chest pain—Brinzolamide—glaucoma	0.000854	0.00254	CcSEcCtD
Abiraterone—Myalgia—Brinzolamide—glaucoma	0.000854	0.00254	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00085	0.00253	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000848	0.00252	CcSEcCtD
Abiraterone—Skin disorder—Brimonidine—glaucoma	0.000847	0.00252	CcSEcCtD
Abiraterone—Acute coronary syndrome—Betaxolol—glaucoma	0.000845	0.00251	CcSEcCtD
Abiraterone—Discomfort—Brinzolamide—glaucoma	0.000844	0.00251	CcSEcCtD
Abiraterone—Cough—Pilocarpine—glaucoma	0.000841	0.0025	CcSEcCtD
Abiraterone—Myocardial infarction—Betaxolol—glaucoma	0.000841	0.0025	CcSEcCtD
Abiraterone—Vomiting—Methazolamide—glaucoma	0.000834	0.00248	CcSEcCtD
Abiraterone—Oedema—Dorzolamide—glaucoma	0.000833	0.00247	CcSEcCtD
Abiraterone—Hypertension—Pilocarpine—glaucoma	0.000832	0.00247	CcSEcCtD
Abiraterone—Oedema—Travoprost—glaucoma	0.000829	0.00246	CcSEcCtD
Abiraterone—Rash—Methazolamide—glaucoma	0.000827	0.00246	CcSEcCtD
Abiraterone—Dermatitis—Methazolamide—glaucoma	0.000827	0.00246	CcSEcCtD
Abiraterone—Infection—Travoprost—glaucoma	0.000824	0.00245	CcSEcCtD
Abiraterone—Cardiac disorder—Clonidine—glaucoma	0.000821	0.00244	CcSEcCtD
Abiraterone—Myalgia—Pilocarpine—glaucoma	0.000821	0.00244	CcSEcCtD
Abiraterone—Chest pain—Pilocarpine—glaucoma	0.000821	0.00244	CcSEcCtD
Abiraterone—Infection—Brinzolamide—glaucoma	0.000813	0.00242	CcSEcCtD
Abiraterone—Nasopharyngitis—Timolol—glaucoma	0.000813	0.00242	CcSEcCtD
Abiraterone—Discomfort—Pilocarpine—glaucoma	0.000811	0.00241	CcSEcCtD
Abiraterone—Skin disorder—Travoprost—glaucoma	0.000805	0.00239	CcSEcCtD
Abiraterone—Angiopathy—Clonidine—glaucoma	0.000802	0.00238	CcSEcCtD
Abiraterone—Rash—Latanoprost—glaucoma	0.000801	0.00238	CcSEcCtD
Abiraterone—Dermatitis—Latanoprost—glaucoma	0.0008	0.00238	CcSEcCtD
Abiraterone—Dyspepsia—Acetazolamide—glaucoma	0.0008	0.00238	CcSEcCtD
Abiraterone—Mediastinal disorder—Clonidine—glaucoma	0.000797	0.00237	CcSEcCtD
Abiraterone—Skin disorder—Brinzolamide—glaucoma	0.000795	0.00236	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000794	0.00236	CcSEcCtD
Abiraterone—Arrhythmia—Clonidine—glaucoma	0.00079	0.00235	CcSEcCtD
Abiraterone—Insomnia—Brimonidine—glaucoma	0.000789	0.00234	CcSEcCtD
Abiraterone—Oedema—Pilocarpine—glaucoma	0.000787	0.00234	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000784	0.00233	CcSEcCtD
Abiraterone—Fatigue—Acetazolamide—glaucoma	0.000783	0.00233	CcSEcCtD
Abiraterone—Infection—Pilocarpine—glaucoma	0.000782	0.00232	CcSEcCtD
Abiraterone—Dyspnoea—Brimonidine—glaucoma	0.000777	0.00231	CcSEcCtD
Abiraterone—Mental disorder—Clonidine—glaucoma	0.000775	0.0023	CcSEcCtD
Abiraterone—Dyspepsia—Brimonidine—glaucoma	0.000767	0.00228	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000759	0.00225	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Travoprost—glaucoma	0.000755	0.00224	CcSEcCtD
Abiraterone—Insomnia—Dorzolamide—glaucoma	0.000753	0.00224	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000753	0.00224	CcSEcCtD
Abiraterone—Fatigue—Brimonidine—glaucoma	0.000752	0.00223	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000746	0.00222	CcSEcCtD
Abiraterone—Dyspnoea—Dorzolamide—glaucoma	0.000742	0.00221	CcSEcCtD
Abiraterone—Insomnia—Brinzolamide—glaucoma	0.00074	0.0022	CcSEcCtD
Abiraterone—Dyspnoea—Travoprost—glaucoma	0.000739	0.0022	CcSEcCtD
Abiraterone—Dyspepsia—Dorzolamide—glaucoma	0.000733	0.00218	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Timolol—glaucoma	0.00073	0.00217	CcSEcCtD
Abiraterone—Dyspnoea—Brinzolamide—glaucoma	0.00073	0.00217	CcSEcCtD
Abiraterone—Dyspepsia—Travoprost—glaucoma	0.00073	0.00217	CcSEcCtD
Abiraterone—Asthenia—Apraclonidine—glaucoma	0.000729	0.00217	CcSEcCtD
Abiraterone—Dyspepsia—Brinzolamide—glaucoma	0.000721	0.00214	CcSEcCtD
Abiraterone—Body temperature increased—Acetazolamide—glaucoma	0.000718	0.00213	CcSEcCtD
Abiraterone—Fatigue—Dorzolamide—glaucoma	0.000718	0.00213	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000717	0.00213	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Travoprost—glaucoma	0.000716	0.00213	CcSEcCtD
Abiraterone—Fatigue—Travoprost—glaucoma	0.000715	0.00212	CcSEcCtD
Abiraterone—Cardiac disorder—Betaxolol—glaucoma	0.000715	0.00212	CcSEcCtD
Abiraterone—Insomnia—Pilocarpine—glaucoma	0.000712	0.00211	CcSEcCtD
Abiraterone—Constipation—Travoprost—glaucoma	0.000709	0.00211	CcSEcCtD
Abiraterone—Hyperglycaemia—Timolol—glaucoma	0.000709	0.00211	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000707	0.0021	CcSEcCtD
Abiraterone—Asthenia—Bimatoprost—glaucoma	0.000706	0.0021	CcSEcCtD
Abiraterone—Fatigue—Brinzolamide—glaucoma	0.000706	0.0021	CcSEcCtD
Abiraterone—Dyspnoea—Pilocarpine—glaucoma	0.000701	0.00208	CcSEcCtD
Abiraterone—Angiopathy—Betaxolol—glaucoma	0.000699	0.00208	CcSEcCtD
Abiraterone—Diarrhoea—Apraclonidine—glaucoma	0.000695	0.00206	CcSEcCtD
Abiraterone—Mediastinal disorder—Betaxolol—glaucoma	0.000694	0.00206	CcSEcCtD
Abiraterone—Dyspepsia—Pilocarpine—glaucoma	0.000693	0.00206	CcSEcCtD
Abiraterone—Arrhythmia—Betaxolol—glaucoma	0.000688	0.00204	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000679	0.00202	CcSEcCtD
Abiraterone—Mental disorder—Betaxolol—glaucoma	0.000674	0.002	CcSEcCtD
Abiraterone—Constipation—Pilocarpine—glaucoma	0.000673	0.002	CcSEcCtD
Abiraterone—Cough—Clonidine—glaucoma	0.000672	0.002	CcSEcCtD
Abiraterone—Body temperature increased—Dorzolamide—glaucoma	0.000658	0.00196	CcSEcCtD
Abiraterone—Chest pain—Clonidine—glaucoma	0.000655	0.00195	CcSEcCtD
Abiraterone—Asthenia—Acetazolamide—glaucoma	0.000652	0.00194	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000651	0.00193	CcSEcCtD
Abiraterone—Discomfort—Clonidine—glaucoma	0.000648	0.00192	CcSEcCtD
Abiraterone—Vomiting—Apraclonidine—glaucoma	0.000646	0.00192	CcSEcCtD
Abiraterone—Dermatitis—Apraclonidine—glaucoma	0.00064	0.0019	CcSEcCtD
Abiraterone—Oedema—Clonidine—glaucoma	0.000628	0.00187	CcSEcCtD
Abiraterone—Asthenia—Brimonidine—glaucoma	0.000626	0.00186	CcSEcCtD
Abiraterone—Infection—Clonidine—glaucoma	0.000624	0.00185	CcSEcCtD
Abiraterone—Body temperature increased—Pilocarpine—glaucoma	0.000622	0.00185	CcSEcCtD
Abiraterone—Diarrhoea—Acetazolamide—glaucoma	0.000622	0.00185	CcSEcCtD
Abiraterone—Rash—Bimatoprost—glaucoma	0.000621	0.00184	CcSEcCtD
Abiraterone—Dermatitis—Bimatoprost—glaucoma	0.00062	0.00184	CcSEcCtD
Abiraterone—Anaemia—Betaxolol—glaucoma	0.000619	0.00184	CcSEcCtD
Abiraterone—Connective tissue disorder—Timolol—glaucoma	0.000618	0.00184	CcSEcCtD
Abiraterone—Skin disorder—Clonidine—glaucoma	0.00061	0.00181	CcSEcCtD
Abiraterone—Asthenia—Dorzolamide—glaucoma	0.000597	0.00178	CcSEcCtD
Abiraterone—Asthenia—Travoprost—glaucoma	0.000595	0.00177	CcSEcCtD
Abiraterone—Asthenia—Brinzolamide—glaucoma	0.000587	0.00175	CcSEcCtD
Abiraterone—Cough—Betaxolol—glaucoma	0.000585	0.00174	CcSEcCtD
Abiraterone—Cardiac disorder—Timolol—glaucoma	0.000584	0.00173	CcSEcCtD
Abiraterone—Vomiting—Acetazolamide—glaucoma	0.000578	0.00172	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000572	0.0017	CcSEcCtD
Abiraterone—Angiopathy—Timolol—glaucoma	0.000571	0.0017	CcSEcCtD
Abiraterone—Myalgia—Betaxolol—glaucoma	0.000571	0.0017	CcSEcCtD
Abiraterone—Chest pain—Betaxolol—glaucoma	0.000571	0.0017	CcSEcCtD
Abiraterone—Diarrhoea—Dorzolamide—glaucoma	0.00057	0.00169	CcSEcCtD
Abiraterone—Insomnia—Clonidine—glaucoma	0.000568	0.00169	CcSEcCtD
Abiraterone—Diarrhoea—Travoprost—glaucoma	0.000567	0.00169	CcSEcCtD
Abiraterone—Mediastinal disorder—Timolol—glaucoma	0.000567	0.00168	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000567	0.00168	CcSEcCtD
Abiraterone—Asthenia—Pilocarpine—glaucoma	0.000564	0.00168	CcSEcCtD
Abiraterone—Discomfort—Betaxolol—glaucoma	0.000564	0.00168	CcSEcCtD
Abiraterone—Arrhythmia—Timolol—glaucoma	0.000562	0.00167	CcSEcCtD
Abiraterone—Dyspnoea—Clonidine—glaucoma	0.00056	0.00166	CcSEcCtD
Abiraterone—Diarrhoea—Brinzolamide—glaucoma	0.00056	0.00166	CcSEcCtD
Abiraterone—Mental disorder—Timolol—glaucoma	0.000551	0.00164	CcSEcCtD
Abiraterone—Rash—Brimonidine—glaucoma	0.00055	0.00163	CcSEcCtD
Abiraterone—Dermatitis—Brimonidine—glaucoma	0.000549	0.00163	CcSEcCtD
Abiraterone—Oedema—Betaxolol—glaucoma	0.000547	0.00163	CcSEcCtD
Abiraterone—Infection—Betaxolol—glaucoma	0.000543	0.00161	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Clonidine—glaucoma	0.000542	0.00161	CcSEcCtD
Abiraterone—Fatigue—Clonidine—glaucoma	0.000542	0.00161	CcSEcCtD
Abiraterone—Diarrhoea—Pilocarpine—glaucoma	0.000538	0.0016	CcSEcCtD
Abiraterone—Constipation—Clonidine—glaucoma	0.000537	0.0016	CcSEcCtD
Abiraterone—Skin disorder—Betaxolol—glaucoma	0.000531	0.00158	CcSEcCtD
Abiraterone—Vomiting—Dorzolamide—glaucoma	0.000529	0.00157	CcSEcCtD
Abiraterone—Rash—Dorzolamide—glaucoma	0.000525	0.00156	CcSEcCtD
Abiraterone—Dermatitis—Dorzolamide—glaucoma	0.000524	0.00156	CcSEcCtD
Abiraterone—Rash—Travoprost—glaucoma	0.000523	0.00155	CcSEcCtD
Abiraterone—Dermatitis—Travoprost—glaucoma	0.000522	0.00155	CcSEcCtD
Abiraterone—Vomiting—Brinzolamide—glaucoma	0.00052	0.00155	CcSEcCtD
Abiraterone—Rash—Brinzolamide—glaucoma	0.000516	0.00153	CcSEcCtD
Abiraterone—Dermatitis—Brinzolamide—glaucoma	0.000516	0.00153	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—NARFL—glaucoma	0.000503	0.0103	CbGpPWpGaD
Abiraterone—Vomiting—Pilocarpine—glaucoma	0.0005	0.00149	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000498	0.00148	CcSEcCtD
Abiraterone—Body temperature increased—Clonidine—glaucoma	0.000497	0.00148	CcSEcCtD
Abiraterone—Rash—Pilocarpine—glaucoma	0.000496	0.00147	CcSEcCtD
Abiraterone—Dermatitis—Pilocarpine—glaucoma	0.000496	0.00147	CcSEcCtD
Abiraterone—Insomnia—Betaxolol—glaucoma	0.000495	0.00147	CcSEcCtD
Abiraterone—ABCC1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000492	0.0101	CbGpPWpGaD
Abiraterone—Dyspnoea—Betaxolol—glaucoma	0.000488	0.00145	CcSEcCtD
Abiraterone—SULT2A1—E2F transcription factor network—CDKN1B—glaucoma	0.000484	0.00991	CbGpPWpGaD
Abiraterone—Dyspepsia—Betaxolol—glaucoma	0.000481	0.00143	CcSEcCtD
Abiraterone—ABCC1—S1P1 pathway—PTGS2—glaucoma	0.000481	0.00983	CbGpPWpGaD
Abiraterone—Cough—Timolol—glaucoma	0.000478	0.00142	CcSEcCtD
Abiraterone—Hypertension—Timolol—glaucoma	0.000473	0.0014	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000472	0.0014	CcSEcCtD
Abiraterone—Fatigue—Betaxolol—glaucoma	0.000472	0.0014	CcSEcCtD
Abiraterone—Constipation—Betaxolol—glaucoma	0.000468	0.00139	CcSEcCtD
Abiraterone—Chest pain—Timolol—glaucoma	0.000466	0.00139	CcSEcCtD
Abiraterone—Myalgia—Timolol—glaucoma	0.000466	0.00139	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000465	0.00951	CbGpPWpGaD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000463	0.00138	CcSEcCtD
Abiraterone—Discomfort—Timolol—glaucoma	0.000461	0.00137	CcSEcCtD
Abiraterone—ALB—HDL-mediated lipid transport—APOE—glaucoma	0.00046	0.00941	CbGpPWpGaD
Abiraterone—SULT2A1—Biological oxidations—GSTM1—glaucoma	0.000457	0.00935	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—GSTM1—glaucoma	0.000451	0.00922	CbGpPWpGaD
Abiraterone—Asthenia—Clonidine—glaucoma	0.000451	0.00134	CcSEcCtD
Abiraterone—Oedema—Timolol—glaucoma	0.000447	0.00133	CcSEcCtD
Abiraterone—Infection—Timolol—glaucoma	0.000444	0.00132	CcSEcCtD
Abiraterone—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000441	0.00903	CbGpPWpGaD
Abiraterone—Skin disorder—Timolol—glaucoma	0.000434	0.00129	CcSEcCtD
Abiraterone—Body temperature increased—Betaxolol—glaucoma	0.000432	0.00128	CcSEcCtD
Abiraterone—Diarrhoea—Clonidine—glaucoma	0.00043	0.00128	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Timolol—glaucoma	0.000407	0.00121	CcSEcCtD
Abiraterone—Insomnia—Timolol—glaucoma	0.000404	0.0012	CcSEcCtD
Abiraterone—ALB—Lipoprotein metabolism—ABCA1—glaucoma	0.000402	0.00822	CbGpPWpGaD
Abiraterone—Vomiting—Clonidine—glaucoma	0.000399	0.00119	CcSEcCtD
Abiraterone—Dyspnoea—Timolol—glaucoma	0.000398	0.00118	CcSEcCtD
Abiraterone—Rash—Clonidine—glaucoma	0.000396	0.00118	CcSEcCtD
Abiraterone—Dermatitis—Clonidine—glaucoma	0.000396	0.00118	CcSEcCtD
Abiraterone—Dyspepsia—Timolol—glaucoma	0.000393	0.00117	CcSEcCtD
Abiraterone—Asthenia—Betaxolol—glaucoma	0.000392	0.00117	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Timolol—glaucoma	0.000386	0.00115	CcSEcCtD
Abiraterone—Fatigue—Timolol—glaucoma	0.000385	0.00114	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—GSTT1—glaucoma	0.000381	0.00779	CbGpPWpGaD
Abiraterone—ABCC1—S1P1 pathway—VEGFA—glaucoma	0.000379	0.00774	CbGpPWpGaD
Abiraterone—Diarrhoea—Betaxolol—glaucoma	0.000374	0.00111	CcSEcCtD
Abiraterone—Body temperature increased—Timolol—glaucoma	0.000353	0.00105	CcSEcCtD
Abiraterone—Vomiting—Betaxolol—glaucoma	0.000348	0.00103	CcSEcCtD
Abiraterone—Rash—Betaxolol—glaucoma	0.000345	0.00102	CcSEcCtD
Abiraterone—Dermatitis—Betaxolol—glaucoma	0.000345	0.00102	CcSEcCtD
Abiraterone—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000341	0.00697	CbGpPWpGaD
Abiraterone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000326	0.00668	CbGpPWpGaD
Abiraterone—Asthenia—Timolol—glaucoma	0.000321	0.000953	CcSEcCtD
Abiraterone—Diarrhoea—Timolol—glaucoma	0.000306	0.000909	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—CYP1B1—glaucoma	0.000303	0.00621	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000299	0.00612	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000292	0.00598	CbGpPWpGaD
Abiraterone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000288	0.0059	CbGpPWpGaD
Abiraterone—Vomiting—Timolol—glaucoma	0.000284	0.000844	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000283	0.0058	CbGpPWpGaD
Abiraterone—Rash—Timolol—glaucoma	0.000282	0.000837	CcSEcCtD
Abiraterone—Dermatitis—Timolol—glaucoma	0.000281	0.000836	CcSEcCtD
Abiraterone—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000276	0.00564	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000275	0.00562	CbGpPWpGaD
Abiraterone—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000269	0.00549	CbGpPWpGaD
Abiraterone—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.000267	0.00546	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CA5A—glaucoma	0.000267	0.00546	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NARFL—glaucoma	0.000267	0.00546	CbGpPWpGaD
Abiraterone—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000264	0.00541	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000263	0.00538	CbGpPWpGaD
Abiraterone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000261	0.00534	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CA1—glaucoma	0.000246	0.00502	CbGpPWpGaD
Abiraterone—CYP17A1—Biological oxidations—GSTM1—glaucoma	0.000243	0.00496	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—GSTM1—glaucoma	0.000239	0.00489	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CTSA—glaucoma	0.000238	0.00487	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000234	0.00479	CbGpPWpGaD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000232	0.00475	CbGpPWpGaD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000229	0.00468	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CA2—glaucoma	0.000225	0.00459	CbGpPWpGaD
Abiraterone—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000224	0.00459	CbGpPWpGaD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000223	0.00456	CbGpPWpGaD
Abiraterone—ABCC1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000222	0.00453	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00022	0.00449	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00022	0.00449	CbGpPWpGaD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000219	0.00447	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—TGFB2—glaucoma	0.000216	0.00441	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—ABCA1—glaucoma	0.000214	0.00437	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000211	0.00431	CbGpPWpGaD
Abiraterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000206	0.00421	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000205	0.0042	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000197	0.00404	CbGpPWpGaD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000196	0.00401	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—SOD1—glaucoma	0.000191	0.0039	CbGpPWpGaD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000191	0.0039	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000188	0.00385	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000188	0.00385	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000186	0.0038	CbGpPWpGaD
Abiraterone—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000176	0.00359	CbGpPWpGaD
Abiraterone—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000174	0.00356	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000173	0.00354	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000171	0.0035	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.00017	0.00347	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—SOD1—glaucoma	0.000163	0.00334	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CA5A—glaucoma	0.000161	0.00329	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NARFL—glaucoma	0.000161	0.00329	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000159	0.00325	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—TXN—glaucoma	0.000158	0.00324	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000156	0.00318	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000154	0.00316	CbGpPWpGaD
Abiraterone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000154	0.00315	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000151	0.0031	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—MTHFR—glaucoma	0.000151	0.00309	CbGpPWpGaD
Abiraterone—ABCC1—Disease—LRP12—glaucoma	0.000146	0.00298	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000144	0.00295	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000143	0.00293	CbGpPWpGaD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.000142	0.00291	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000141	0.00288	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000132	0.00269	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CA1—glaucoma	0.00013	0.00267	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CTSA—glaucoma	0.000126	0.00258	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTT1—glaucoma	0.000125	0.00257	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000125	0.00255	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000123	0.00251	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSTT1—glaucoma	0.000123	0.00251	CbGpPWpGaD
Abiraterone—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	0.000121	0.00248	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.00012	0.00245	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CA2—glaucoma	0.000119	0.00244	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000116	0.00238	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000116	0.00238	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—FN1—glaucoma	0.000114	0.00233	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000108	0.00222	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000107	0.00219	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000103	0.00211	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTT1—glaucoma	0.000103	0.00211	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000101	0.00207	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP1B1—glaucoma	9.99e-05	0.00204	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.89e-05	0.00202	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	9.86e-05	0.00202	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP1B1—glaucoma	9.78e-05	0.002	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ABCA1—glaucoma	9.78e-05	0.002	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.64e-05	0.00197	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	9.56e-05	0.00196	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGFR1OP—glaucoma	9.39e-05	0.00192	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HEYL—glaucoma	9.39e-05	0.00192	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.34e-05	0.00191	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.28e-05	0.0019	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA5A—glaucoma	8.79e-05	0.0018	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NARFL—glaucoma	8.79e-05	0.0018	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NARFL—glaucoma	8.74e-05	0.00179	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA5A—glaucoma	8.74e-05	0.00179	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TXN—glaucoma	8.4e-05	0.00172	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP1B1—glaucoma	8.2e-05	0.00168	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	8.09e-05	0.00166	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—TNF—glaucoma	8e-05	0.00164	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTM1—glaucoma	7.99e-05	0.00163	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	7.88e-05	0.00161	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CA1—glaucoma	7.86e-05	0.00161	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSTM1—glaucoma	7.82e-05	0.0016	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.66e-05	0.00157	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	7.66e-05	0.00157	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CTSA—glaucoma	7.61e-05	0.00156	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.59e-05	0.00155	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	7.25e-05	0.00148	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NARFL—glaucoma	7.22e-05	0.00148	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA5A—glaucoma	7.22e-05	0.00148	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CA2—glaucoma	7.19e-05	0.00147	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.15e-05	0.00146	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.03e-05	0.00144	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.03e-05	0.00144	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—MTHFR—glaucoma	6.91e-05	0.00141	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.73e-05	0.00138	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTM1—glaucoma	6.56e-05	0.00134	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTT1—glaucoma	6.51e-05	0.00133	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—glaucoma	6.51e-05	0.00133	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TNF—glaucoma	6.51e-05	0.00133	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	6.47e-05	0.00132	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—APOE—glaucoma	6.43e-05	0.00132	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CAV1—glaucoma	6.37e-05	0.0013	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	6.2e-05	0.00127	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HDAC9—glaucoma	5.86e-05	0.0012	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—glaucoma	5.74e-05	0.00117	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.36e-05	0.0011	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.29e-05	0.00108	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.25e-05	0.00107	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.23e-05	0.00107	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1B1—glaucoma	5.19e-05	0.00106	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ABCA1—glaucoma	5.19e-05	0.00106	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—TNF—glaucoma	5.17e-05	0.00106	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TXN—glaucoma	5.07e-05	0.00104	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	5.04e-05	0.00103	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB2—glaucoma	4.93e-05	0.00101	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—NOS3—glaucoma	4.82e-05	0.000986	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NARFL—glaucoma	4.72e-05	0.000965	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA5A—glaucoma	4.72e-05	0.000965	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.62e-05	0.000946	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.58e-05	0.000937	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTGS2—glaucoma	4.41e-05	0.000901	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA1—glaucoma	4.29e-05	0.000878	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.29e-05	0.000877	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA1—glaucoma	4.27e-05	0.000873	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.23e-05	0.000865	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CTSA—glaucoma	4.16e-05	0.00085	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTM1—glaucoma	4.15e-05	0.000848	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CTSA—glaucoma	4.13e-05	0.000846	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTT1—glaucoma	3.93e-05	0.000803	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CA2—glaucoma	3.93e-05	0.000803	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CA2—glaucoma	3.9e-05	0.000799	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.84e-05	0.000785	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.84e-05	0.000785	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.82e-05	0.000781	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.82e-05	0.000781	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SOD1—glaucoma	3.74e-05	0.000764	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—MTHFR—glaucoma	3.67e-05	0.00075	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA1—glaucoma	3.52e-05	0.000721	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CTSA—glaucoma	3.41e-05	0.000698	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—APOE—glaucoma	3.41e-05	0.000698	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CAV1—glaucoma	3.38e-05	0.000692	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA2—glaucoma	3.22e-05	0.000659	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.17e-05	0.000648	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN2B—glaucoma	3.15e-05	0.000644	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ABCA1—glaucoma	3.13e-05	0.00064	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1B1—glaucoma	3.13e-05	0.00064	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.89e-05	0.00059	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MMP1—glaucoma	2.85e-05	0.000583	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TXN—glaucoma	2.77e-05	0.000566	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TXN—glaucoma	2.75e-05	0.000563	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CAV1—glaucoma	2.73e-05	0.000559	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTHFR—glaucoma	2.64e-05	0.00054	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—FN1—glaucoma	2.6e-05	0.000532	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NOS3—glaucoma	2.56e-05	0.000523	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.52e-05	0.000516	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.51e-05	0.000513	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—glaucoma	2.5e-05	0.000512	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.5e-05	0.000512	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.49e-05	0.000509	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APOE—glaucoma	2.46e-05	0.000503	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CAV1—glaucoma	2.44e-05	0.000498	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—glaucoma	2.34e-05	0.000478	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA1—glaucoma	2.3e-05	0.000471	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BAD—glaucoma	2.29e-05	0.000469	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TXN—glaucoma	2.27e-05	0.000465	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CTSA—glaucoma	2.23e-05	0.000456	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—glaucoma	2.21e-05	0.000452	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTT1—glaucoma	2.14e-05	0.000439	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTT1—glaucoma	2.13e-05	0.000436	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA2—glaucoma	2.11e-05	0.000431	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS3—glaucoma	2.07e-05	0.000422	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOE—glaucoma	2.06e-05	0.000421	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CAV1—glaucoma	2.04e-05	0.000417	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—glaucoma	1.84e-05	0.000377	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—glaucoma	1.76e-05	0.00036	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.73e-05	0.000354	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.72e-05	0.000352	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1B1—glaucoma	1.71e-05	0.00035	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCA1—glaucoma	1.71e-05	0.00035	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1B1—glaucoma	1.7e-05	0.000348	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCA1—glaucoma	1.7e-05	0.000348	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—glaucoma	1.68e-05	0.000345	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—glaucoma	1.6e-05	0.000326	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—glaucoma	1.54e-05	0.000315	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—glaucoma	1.49e-05	0.000304	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TXN—glaucoma	1.48e-05	0.000304	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—glaucoma	1.41e-05	0.000289	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCA1—glaucoma	1.4e-05	0.000287	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1B1—glaucoma	1.4e-05	0.000287	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—glaucoma	1.37e-05	0.000279	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—glaucoma	1.36e-05	0.000278	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—glaucoma	1.21e-05	0.000247	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—glaucoma	1.2e-05	0.000246	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—glaucoma	1.15e-05	0.000236	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—glaucoma	1.12e-05	0.00023	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOE—glaucoma	1.12e-05	0.00023	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—glaucoma	1.12e-05	0.000229	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOE—glaucoma	1.12e-05	0.000229	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAV1—glaucoma	1.11e-05	0.000228	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAV1—glaucoma	1.11e-05	0.000227	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—glaucoma	9.91e-06	0.000203	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOE—glaucoma	9.23e-06	0.000189	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1B1—glaucoma	9.17e-06	0.000188	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCA1—glaucoma	9.17e-06	0.000188	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAV1—glaucoma	9.14e-06	0.000187	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—glaucoma	8.42e-06	0.000172	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—glaucoma	8.37e-06	0.000171	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—glaucoma	7.7e-06	0.000158	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—glaucoma	7.66e-06	0.000157	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—glaucoma	7.33e-06	0.00015	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—glaucoma	6.91e-06	0.000141	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—glaucoma	6.48e-06	0.000133	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—glaucoma	6.32e-06	0.000129	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOE—glaucoma	6.03e-06	0.000123	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAV1—glaucoma	5.98e-06	0.000122	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—glaucoma	4.52e-06	9.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—glaucoma	4.13e-06	8.46e-05	CbGpPWpGaD
